PTAB 4 Years In: PGRs ready for primetime
Post-grant review petition filing this year is already higher than the whole of 2015, with biopharma companies leading the way. Michael Loney analyses PGRs’ appeal and what strategies filers should consider
Petition filing at the Patent Trial and Appeal Board (PTAB)
down so far this year compared with 2015, but demand is
growing for one type of petition – post-grant review,
As of August 16, 32 PGR petitions...
Please log in
to read the rest of this article. New to Managing Intellectual Property?
Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.
Please make sure you log in to read the rest of the article.
Join us nowGain FREE access to up to five free articles when you register now.